Heska posts Q2 losses

LOVELAND — Heska Corp. (NASDAQ: HSKA), a Loveland-based veterinary diagnostic product maker, posted losses of $0.03 per share on revenues of $28.1 million for the second quarter of fiscal year 2019.

That’s down from a profit of $0.26 per share on revenues of $29.7 million during the same quarter last year.

Total operating expenses in the second quarter of 2019 were $13.0 million, compared to $10.9 million in the prior year. “The increase in operating expenses was primarily due to an increase of $1.7 million in research and development related to new product development initiatives, and an increase of $0.8 million in selling and marketing due to expanded domestic headcount in the latter half of 2018 and expanded international operations,” according to Heska’s second quarter earnings report released Tuesday.

SPONSORED CONTENT

Business Cares: April 2024

In Colorado, 1 in 3 women, 1 in 3 men and 1 in 2 transgender individuals will experience an attempted or completed sexual assault in their lifetime. During April, we recognize Sexual Assault Awareness Month with the hopes of increasing conversations about this very important issue.

This fiscal year “is shaping up to be the most positively transformative period in Heska’s history,” CEO Kevin Wilson said in a prepared statement. “Heska is simultaneously:  driving internationally to more than double the customers and potential customers we serve; developing and launching major first-to-market, best-in-class innovations; growing our core subscriber base;  deploying capital for accelerated growth; and scaling our capabilities.”